Overview

Inflation Device Market Introduction

Inflation Device Market to value over US $ 590 million and grow at a CAGR of over 4% during the forecast period from 2020 to 2027.

 With an increase in the incidence of target diseases, given the high risk and exposure to chronic diseases due to an unhealthy sedentary lifestyle and rising geriatric population, all these factors accelerate, promote and positively push the global market. Furthermore, adding to these factors, beneficial medical reimbursement for minimally invasive procedures in developed countries, advancing demand for minimally invasive surgical procedures across global powers, and increasing applications of inflation devices are the principal determinants driving the growth of the inflation devices market. Government initiatives to control the burden of healthcare-associated infections in developed countries and escalating healthcare expenditure across emerging markets are further assisting market growth.

In terms of market segmentation, in terms of the capacity segment, the global market is differentiated into 20ml, 30ml, and 60ml inflation devices. The 60ml inflation devices segment is anticipated to flourish at the most active CAGR during the forecast period. These devices have easy accessibility and mechanisms and are intended to be handy, which has promoted their application in various industries. Implementation of these devices in pulmonary, gastroenterology, and otolaryngology procedures is growing increasingly popular, as these techniques utilize comparatively larger-sized balloons and requires more liquid for inflation.

According to the application, the market is characterized by interventional cardiology, interventional radiology, peripheral vascular procedures, urological procedures, gastroenterological procedures, and other applications. Among these, the interventional cardiology segment valued for the most substantial share of the inflation device market. The mounting ageing population is more predisposed to develop CVD, which is a significant circumstance driving the adoption of interventional cardiology procedures that utilizes inflation devices. Furthermore, mushrooming in the quantity of new multi-specialty hospitals in developing countries offering advanced minimally invasive procedures, promising reimbursement scenario for angioplasty procedures will additionally stimulate the growth of the division over the forecast period.

In terms of end-user, the hospitals and clinics segment is the largest contributor to the inflation devices market due to the expanding amount of hospitals and specialty clinics in developing nations, the growing predominance of target diseases; and a considerable number of surgical and diagnostic procedures implemented across these amenities.

Asia Pacific is anticipated to advance at the highest CAGR in the market during the forecast period. North America is foreseen to value for the most considerable share in the global market. Business germination is motivated by the increasing frequency of minimally invasive surgical procedures, advancing healthcare infrastructure, rising awareness about HAIs and the use of disposable devices, and the increasing adoption of minimally invasive procedures.

Major market companies operating globally are:

Merit Medical Systems (US), Boston Scientific Corporation (US), Cardinal Health (US), CONMED Corporation (US), Medtronic plc (Ireland), Acclarent Inc. (US), Cook Medical (US), Atrion Corporation (US), Becton, Dickinson and Company (US), Terumo Medical Corporation (Japan), B. Braun Melsungen AG (US), Olympus Corporation (Japan), Teleflex Incorporated (US), and US Endovascular (US), among others.

Major market firms are undertaking strategic initiatives to increase their presence in emerging countries to leverage the growth opportunities in these markets will further contribute to the market growth.

Market Segmentation

By Capacity

●         20ml Inflation Devices

●         30ml Inflation Devices

●         60ml Inflation Devices

By Display Type

●        Analog Inflation Devices

●        Digital Inflation Devices

By Application

●     Interventional Cardiology

●     Interventional Radiology

●     Peripheral Vascular Procedures

●     Gastroenterological Procedures

●     Urological Procedures

●     Other Applications

By End User

●       Hospitals and Clinics

●       Ambulatory Surgery Centers

By Region:

●      Europe

●      North America

●      APAC

●      Latin America

●      Rest of World

Competitive Landscape:

●      Tier 1 players- established companies in the market with a major market share

●      Tier 2 players

●      Emerging players which are growing rapidly

●      New Entrants 

FutureWise Takeaways

●      Growth prospects

●      SWOT analysis

●      Key trends

●      Key data points affecting market growth

Objectives of the Study:

●     To provide an exhaustive analysis on the global market by capacity, by display type, by application, by end-user, and by region

●      To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)

●      To evaluate and forecast micro-markets and the overall market

●      To predict the market size, in key regions (along with countries)—North America, Europe, Asia Pacific, Latin America, and the rest of the world

●      To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions

●      Profiling of companies to evaluate their market shares, strategies, financials and core competencies

Table of Contents

1 Introduction
    1.1 Objectives of the Study 
    1.2 Market Definition 
    1.3 Market Scope 
           1.3.1 Markets Covered
           1.3.2 Years Considered for the Study
    1.4 Currency 
    1.5 Stakeholders 

2 Research Methodology 
    2.1 Research Data 
           2.1.1 Secondary Data
                    2.1.1.1 Key Data From Secondary Sources
           2.1.2 Primary Data
                    2.1.2.1 Key Data From Primary Sources
                    2.1.2.2 Breakdown of Primaries
    2.2 Market Estimation Methodology 
           2.2.1 Product-Based Market Estimation
           2.2.2 Primary Research Validation
    2.3 Market Breakdown and Data Triangulation 
    2.4 Research Limitations and Assumptions 
           2.4.1 Limitations
           2.4.2 Assumptions

3 Executive Summary 

4 Premium Insights 

    4.1 Market Overview 
    4.2 Geographic Analysis: Inflation Device Market, By Display Type and Region 
    4.3 Geographic Analysis: Market, By Capacity and Region 
    4.4 Market, By Application 
    4.5 Geographic Snapshot of the market 

5 Market Overview 
    5.1 Introduction 
    5.2 Market Dynamics 
           5.2.1 Drivers
                    5.2.1.1 Rising Geriatric Population
                    5.2.1.2 Increasing Preference for Minimally Invasive Surgeries
                    5.2.1.3 Favorable Reimbursement Scenario for Cardiovascular Procedures
           5.2.2 Restraints
                    5.2.2.1 Availability of Effective Alternative Treatments
                    5.2.2.2 High Rate of Reprocessing Inflation Devices
           5.2.3 Opportunities
                    5.2.3.1 Emerging Economies Offer High-Growth Potential
                    5.2.3.2 Rising Awareness About Hospital-Acquired Infections and the Rising Adoption of Disposable Accessories
           5.2.4 Challenges
                    5.2.4.1 Product Recalls
                    5.2.4.2 Presence of Local Manufacturers and Pricing Pressure

6 Inflation Device Market, By Capacity 
    6.1 Introduction 
    6.2 20ml Inflation Devices 
           6.2.1 Easy Availability of 20ml Inflation Devices and Wide Range of Offerings are Driving the Growth of This Market Segment
    6.3 30ml Inflation Devices 
           6.3.1 30ml Inflation Devices Offer Digital Or Analog Displays
    6.4 60ml Inflation Devices 
           6.4.1 60ml Inflation Devices to Witness Highest Growth During the Forecast Period

7 Inflation Device Market, By Display Type 
    7.1 Introduction 
    7.2 Analog Inflation Devices 
           7.2.1 Analog Inflation Devices Accounted for the Larger Market Share Primarily Due to the Low Cost and Portability Associated With These Devices
    7.3 Digital Inflation Devices 
           7.3.1 High Growth of the Digital Inflation Devices Segment is Attributed to the Advanced Display Patterns and Ease of Use Associated With These Devices

8 Inflation Device Market, By Application 
    8.1 Introduction 
    8.2 Interventional Cardiology 
           8.2.1 Interventional Cardiology Forms the Largest Application Segment of the Inflation Devices Market
    8.3 Interventional Radiology 
           8.3.1 Increasing Prevalence of Cancer to Drive the Adoption of Inflation Devices for This Application Segment
    8.4 Peripheral Vascular Procedures 
           8.4.1 Increasing Prevalence of Target Diseases to Drive the Market for This Application Segment
    8.5 Gastroenterological Procedures 
           8.5.1 Gastroenterological Procedures Segment to Witness the Highest Growth Primarily Due to the Increasing Incidence of Gastrointestinal Diseases Across the Globe
    8.6 Urological Procedures 
           8.6.1 Growing Prevalence of Urological Disorders & Ongoing Technical Advancements in the Field of Minimally Invasive Urological Treatments to Drive Market Growth
    8.7 Other Applications 

9 Inflation Device Market, By End User 
    9.1 Introduction 
    9.2 Hospitals and Clinics 
           9.2.1 Hospitals Hold the Largest Share of the Market, By End User
    9.3 Ambulatory Surgery Centers 
           9.3.1 Advantages of Ambulatory Care Have Boosted Patient Preference for These Centers

10 Inflation Device Market, By Region 
     10.1 Introduction 
     10.2 North America 
             10.2.1 US
                        10.2.1.1 US Accounts for the Largest Share of the North American Market
             10.2.2 Canada
                        10.2.2.1 Nearly One-Fifth of the Population Suffers From High Blood Pressure
     10.3 Europe 
             10.3.1 Germany
                        10.3.1.1 Germany Had Among the Highest Obesity Rates in 2017
             10.3.2 UK
                        10.3.2.1 Rising Geriatric Population and Well-Developed Healthcare Infrastructure Account for Market Growth
             10.3.3 France
                        10.3.3.1 Favorable Government Support has Expanded Healthcare Access and Medical Tourism in France
             10.3.4 Rest of Europe
     10.4 Asia Pacific 
             10.4.1 China
                        10.4.1.1 China’s Aging Population is Growing at A High Rate
             10.4.2 Japan
                        10.4.2.1 Universal Healthcare Coverage has Allowed for Easy Access to Healthcare in Japan
             10.4.3 India
                        10.4.3.1 High Target Patient Population in India Will Drive Market Growth
             10.4.4 Rest of Asia Pacific
     10.5 Rest of the World 

11 Competitive Landscape 
     11.1 Introduction 
     11.2 Market Ranking 
     11.3 Competitive Scenario 
             11.3.1 Product Launches and Approvals
             11.3.2 Acquisitions
             11.3.3 Expansions
             11.3.4 Partnerships, Agreements, and Collaborations
     11.4 Competitive Leadership Mapping: Major Market Players (2019) 
             11.4.1 Visionary Leaders
             11.4.2 Innovators
             11.4.3 Dynamic Differentiators
             11.4.4 Emerging Companies

12 Company Profiles 
(Business Overview, Products Offered, Recent Developments, FutureWise View)*
     12.1 Advanced Lifesciences Pvt. Ltd. 
     12.2 Acclarent, Inc. (Subsidiary of Johnson & Johnson) 
     12.3 Atrion Corporation 
     12.4 B. Braun Melsungen AG 
     12.5 Becton, Dickinson and Company 
     12.6 Boston Scientific Corporation 
     12.7 Cardinal Health 
     12.8 Conmed Corporation 
     12.9 Cook Medical 
     12.10 Medtronic PLC 
     12.11 Merit Medical Systems 
     12.12 Olympus Corporation 
     12.13 Teleflex Incorporated 
     12.14 Terumo Medical Corporation 
     12.15 US Endovascular 

*Business Overview, Products Offered, Recent Developments, FutureWise View Might Not Be Captured in Case of Unlisted Companies.

Tables

Figures